Impact of Ceftazidime / Avibactam Treatment vs Better Available Therapy on Mortality of Patients With Infections Caused by Carbapenem-resistant Enterobacteria
Latest Information Update: 24 Feb 2022
At a glance
- Drugs Avibactam/ceftazidime (Primary) ; Colistin; Fosfomycin; Gentamicin; Meropenem; Tigecycline
- Indications Enterobacter infections; Intra-abdominal infections; Nosocomial pneumonia; Respiratory tract infections; Urinary tract infections
- Focus Therapeutic Use
- Acronyms CAVICOR
Most Recent Events
- 12 Feb 2022 Results published in the Journal of Antimicrobial Chemotherapy
- 19 Jul 2021 Status changed from recruiting to completed.
- 18 Feb 2020 Planned End Date changed from 1 Apr 2020 to 1 Jun 2020.